Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Canaccord Genuity stays at 'buy' on System1 following CMD event

(Sharecast News) - Analysts at Canaccord Genuity reiterated their 'buy' rating and 450.0p target price on software firm System1 on Thursday following the group's capital markets day event earlier in the week. Canaccord Genuity said Wednesday's capital markets day, in its view, reaffirmed "the impressive progress" that System1 has made since the launch of its strategic review.

"CEO James Gregory described how the refreshed go-to-market strategy has helped drive strong customer momentum for its data and data-led consultancy platform solutions, which enable its customers to predict and improve marketing effectiveness and optimise ROI," said Canaccord, which added that here, new and existing customer revenue was up 237% and 32% year-to-date, respectively.

Chief financial officer Chris Willford reiterated the group's full-year guidance, implying fourth-quarter sales of £7.8m, up 18% year-on-year, which the Canadian bank sees achievable, given run-rate performance, whilst adjusted underlying earnings consensus of £4.1m implied margin improvement of roughly 700 basis points, a trend which was expected to continue as the platform model drives operational gearing from the largely fixed cost base.

"System1's successful execution of strategy is evidenced, in our opinion, in the strengthening financial profile, which in turn has triggered four consecutive upgrades, most recently with the Q3 trading update. Despite this, the shares continue to trade at a >30% discount to peers on a CY24E EV/Sales of 1.2x, which we view to be unwarranted given its highly scalable growth trajectory. We reiterate our 450p target price, equivalent to a CY24E EV/Sales of 1.6x, which is in line with the peer group average," said Canaccord Genuity.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Yellow Cake NAV slips as uranium values decline
(Sharecast News) - Uranium investor Yellow Cake reported a rise in uranium holdings but a decrease in net asset value due to lower spot prices in its interim results on Tuesday.
Digitalbox FY EBITDA now seen ahead of internal expectations
(Sharecast News) - Digital media business Digtalbox said on Tuesday that it now expects FY24 revenues to be at least £3.5m, while underlying earnings were also seen ahead of management's expectations.
Dianomi expects to record small loss in FY24
(Sharecast News) - Digital advertising business Dianomi warned on Tuesday that it and to record a small loss in FY24 compared to market expectations of a small profit.
Ixico secures new contract with US-based client
(Sharecast News) - Neuroscience imaging firm Ixico has signed a contract with a new US-based client to provide imaging services for a Phase 2 Huntington's Disease clinical trial.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.